Neuroendocrine gut–brain signaling in obesity
Trends in Endocrinology & Metabolism · 2025-01 · 36 (1) · 42-54
DOI: 10.1016/j.tem.2024.05.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2025-01. Verfasst von Tim Gruber und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI 49506, USA; Department of Epigenetics, Van Andel Institut…. Hauptthemen laut MEDLINE: Obesity, Neurosecretory Systems, Brain-Gut Axis, Brain. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The past decades have witnessed the rise and fall of several, largely unsuccessful, therapeutic attempts to bring the escalating obesity pandemic to a halt. Looking back to look ahead, the field has now put its highest hopes in translating insights from how the gastrointestinal (GI) tract communicates with the brain to calibrate behavior, physiology, and metabolism. A major focus of this review is to summarize the latest advances in comprehending the neuroendocrine aspects of this so-called 'gut-brain axis' and to explore novel concepts, cutting-edge technologies, and recent paradigm-shifting experiments. These exciting insights continue to refine our understanding of gut-brain crosstalk and are poised to promote the development of additional therapeutic avenues at the dawn of a new era of antiobesity therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI 49506, USA; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49506, USA; German Center for Diabetes Research (D…
- German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany; Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 857…
- Institute of Veterinary Pharmacology and Toxicology, University of Zurich-Vetsuisse, 8057 Zurich, Switzerland; Institute of Neuroscience and Physiology, University of Gothenburg, 40530 Gothenburg, Sweden.
Zitieren
APA
Gruber, T., Lechner, F., Krieger, J. P., & García-Cáceres, C. (2025). Neuroendocrine gut–brain signaling in obesity. Trends in Endocrinology & Metabolism, 36(1), 42-54. https://doi.org/10.1016/j.tem.2024.05.002
Vancouver
Gruber T, Lechner F, Krieger JP, García-Cáceres C. Neuroendocrine gut–brain signaling in obesity. Trends in Endocrinology & Metabolism. 2025;36(1):42-54. doi:10.1016/j.tem.2024.05.002
BibTeX
@article{Gruber2025,
author = {Gruber, Tim and Lechner, Franziska and Krieger, Jean-Philippe and García-Cáceres, Cristina},
title = {Neuroendocrine gut–brain signaling in obesity},
journal = {Trends in Endocrinology & Metabolism},
year = {2025},
volume = {36},
number = {1},
pages = {42--54},
doi = {10.1016/j.tem.2024.05.002}
}
EUVIMED